George Vlachogiannis, Managing Editor of Cancer Control at Sage, shared a post on LinkedIn:
“Incident Delirium in Hospitalized Cancer Patients: Clinical Factors Associated With Mortality and Prolonged Hospitalization
A new study from Moffitt Cancer Center and the University of South Florida published in Cancer Control highlights delirium as a high-impact prognostic signal in acutely hospitalized cancer patients, not just a transient complication.
In a retrospective cohort of 126 non-surgical oncology inpatients who developed incident delirium, in-hospital mortality was 15.9%, and non-survivors had longer delirium duration (3 vs 1 day) plus clear markers of physiologic vulnerability: low albumin, low platelets, low BMI, and higher LDH, along with higher rates of sepsis and greater pre-delirium benzodiazepine exposure. Delirium duration also tracked with longer length of stay, reinforcing delirium as a measurable indicator of declining resilience.
Early recognition of delirium plus rapid assessment of frailty, infection, nutrition, and sedative burden may offer actionable pathways to improve inpatient outcomes in oncology.”
Title: Incident Delirium in Hospitalized Cancer Patients: Clinical Factors Associated With Mortality and Prolonged Hospitalization
Authors: Brandon Dyer, Joel Kallarackal, Robert Baldwin, Aasha Hoogland, Kenneth Snell, Heather Jim, Jeffrey Huang
Read the Full Article.
More from George Vlachogiannis on OncoDaily.